O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+4.92%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.8B
AUM Growth
+$11.8B
(+3.8%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
2.53%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
154
New
22
Increased
42
Reduced
28
Closed
21
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$267M |
| 2 |
Boston Scientific
BSX
|
$145M |
| 3 |
AbbVie
ABBV
|
$124M |
| 4 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$109M |
| 5 |
Community Health Systems
CYH
|
$96.3M |
Top Sells
| 1 |
Perrigo
PRGO
|
$207M |
| 2 |
Zimmer Biomet
ZBH
|
$111M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$107M |
| 4 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$105M |
| 5 |
Stryker
SYK
|
$88.6M |
Sector Composition
| 1 | Healthcare | 87.46% |
| 2 | Financials | 0.24% |
| 3 | Technology | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ironwood Pharmaceuticals
IRWD
$201M
| $150M | 1.25% |
12,402,500
+390,400
| +3% | +$4.71M |
|
27
Intuitive Surgical
ISRG
$158B
| $146M | 1.22% |
301,300
-108,400
| -26% | -$52.5M |
|
28
Agilent Technologies
A
$35.5B
| $142M | 1.18% |
3,668,000
-383,000
| -9% | -$14.8M |
|
|
TSRO
29
DELISTED
TESARO, Inc.
TSRO
| $122M | 1.02% |
2,071,480
+13,780
| +0.7% | +$810K |
|
|
TRNX
30
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $120M | 1% |
4,805,000
| – | – |
|
|
RCPT
31
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $119M | 1% |
628,100
+472,000
| +302% | +$89.7M |
|
|
ESRX
32
DELISTED
Express Scripts Holding Company
ESRX
| $119M | 1% |
1,342,000
+9,000
| +0.7% | +$800K |
|
33
Puma Biotechnology
PBYI
$258M
| $110M | 0.92% |
940,800
+570,600
| +154% | +$66.6M |
|
|
AGN.PRA
34
DELISTED
Allergan plc.
AGN.PRA
| $109M | 0.91% |
+104,200
| New | +$109M |
|
35
Pfizer
PFE
$141B
| $102M | 0.86% |
3,053,000
+69,000
| +2% | +$2.31M |
|
|
MGLN
36
DELISTED
Magellan Health Services, Inc.
MGLN
| $102M | 0.85% |
1,450,700
+35,900
| +3% | +$2.52M |
|
|
37
Community Health Systems
CYH
$392M
| $96.3M | 0.81% |
+1,530,000
| New | +$96.3M |
|
|
INSY
38
DELISTED
Insys Therapeutics, Inc.
INSY
| $94.2M | 0.79% |
2,623,000
+1,379,800
| +111% | +$4.91M |
|
|
MNK
39
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $93.6M | 0.78% |
795,000
+3,999
| +0.5% | +$471K |
|
|
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
| $88.3M | 0.74% |
1,005,200
+4,800
| +0.5% | +$422K |
|
|
WMGI
41
DELISTED
Wright Medical Group Inc
WMGI
| $87.6M | 0.73% |
3,337,000
+810,000
| +32% | +$21.3M |
|
|
ISEE
42
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $87.2M | 0.73% |
1,674,600
+6,000
| +0.4% | +$312K |
|
43
Glaukos
GKOS
$5.42B
| $84M | 0.7% |
+2,897,937
| New | +$84M |
|
|
AFFX
44
DELISTED
AFFYMETRIX INC
AFFX
| $82M | 0.69% |
7,511,000
+160,000
| +2% | +$1.75M |
|
|
ADAP
45
Adaptimmune Therapeutics
ADAP
$13.9M
| $80.9M | 0.68% |
+4,411,186
| New | +$80.9M |
|
|
SIEN
46
DELISTED
Sientra, Inc.
SIEN
| $80.4M | 0.67% |
3,185,306
-2
| -0% | – |
|
|
AFMD
47
DELISTED
Affimed
AFMD
| $78.3M | 0.65% |
5,814,630
| – | – |
|
|
ARRY
48
DELISTED
Array Biopharma Inc
ARRY
| $72.5M | 0.61% |
10,060,500
+828,190
| +9% | +$5.97M |
|
|
NUVA
49
DELISTED
NuVasive, Inc.
NUVA
| $70.5M | 0.59% |
1,487,000
+415,000
| +39% | +$19.7M |
|
50
Johnson & Johnson
JNJ
$429B
| $60.1M | 0.5% |
617,000
+4,000
| +0.7% | +$390K |
|